Gelest Joins Global Fight Against Antimicrobial Resistance
MORRISVILLE, PA – Gelest Inc., Morrisville, Pennsylvania, has joined The Antimicrobial Resistance (AMR) Challenge launched by the U.S. Government and CDC in September 2018. The AMR Challenge is an effort to accelerate the fight against antimicrobial resistance through committed action across governments and industries.
Antimicrobial resistance (AMR) occurs when bacteria, parasites and fungi develop resistance against previously effective antimicrobials. AMR poses an increasingly serious threat to global public health that requires immediate action from government organizations, private companies and society at large. In 2016, it was estimated that more than 700,000 people die each year due to drug-resistant infections. Without further action, infections caused by antimicrobial-resistant superbugs could kill an additional 10 million people each year worldwide by 2050, overtaking cancer as one of the leading global causes of death.